Publications by authors named "Jeanette Jiang"
Article Synopsis
- Antifungal prophylaxis using mold-active triazoles (MATs) is effective in preventing invasive fungal diseases (IFDs) in high-risk, immunocompromised patients, as shown in a study with over 1,177 participants.
- The study found that breakthrough IFDs occurred in only 7.1% of patients, with different MATs showing varying percentages and specific pathogens identified.
- Adverse drug reactions (ADRs) were reported in 14.1% of patients, but discontinuation of MATs due to these reactions was relatively low at 11.1%, supporting their use in at-risk populations.
Background: Despite millions of COVID-19 cases in the United States, it remains unknown whether a history of COVID-19 infection impacts the safety of pharmacologic myocardial perfusion imaging stress testing (pharmacologic MPI).
Hypothesis: The aim of this study was to assess if a prior COVID-19 infection was associated with a higher risk of complications during and following pharmacologic MPI testing.
Methods: This retrospective cohort analysis included 179 803 adults (≥18 years) from the PharMetrics® Plus claims database who underwent pharmacologic MPI between March 1, 2020 and February 28, 2021.
Background: Invasive fungal infections (IFIs) have been identified as a complication in patients with Coronavirus disease 2019 (COVID-19). To date, there are few US studies examining the excess humanistic and economic burden of IFIs on hospitalised COVID-19 patients.
Objectives: This study investigated the incidence, risk factors, clinical and economic burden of IFIs in patients hospitalised with COVID-19 in the United States.